CPhi Preview 2013: Cambridge Laboratories

Article

2013 CPhI Exhibitor Preview

Company: : Cambridge Major Laboratories, Inc. (CML)

Description: CML is a global leader in API development and manufacturing to the pharmaceutical and biotechnology industries. CML produces pharmaceutical intermediates and API’s from preclinical through commercial manufacture. Operating across three facilities in the U.S. and Europe, CML services include process chemistry, API manufacturing, analytical sciences, solid state chemistry and quality assurance.

Website: www.c-mlabs.com

Booth Number: 50C52

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content
Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept. | Image Credit: © Dilok - stock.adobe.com

CordenPharma and Viking Therapeutics to Partner for Integrated Supply of GLP-1s

Patrick Lavery
March 13th 2025
Article

The multi-year strategic partnership is intended to support commercial demand of Viking Therapeutics’ GLP-1 candidate, VK2735.

Drug Solutions Podcast: Forecasting Pharma’s Future

Drug Solutions Podcast: Forecasting Pharma’s Future

Felicity Thomas
January 31st 2025
Podcast

This episode is a compilation of comments taken from a series of interviews where experts reveal the trends that have impacted the bio/pharma industry in 2024 and those they expect to be impactful in 2025.

concept of industry 4 0 technology automation system with cloud computing | Image Credit: © Sasirat - © Sasirat - stock.adobe.com

Accelerating Adoption of Smart Tools to Advance Manufacturing

Feliza Mirasol
March 12th 2025
Article

Industry 4.0 is driving adoption in the pharma industry for smart equipment and tools that will advance manufacturing.

Drug Solutions Podcast: Realizing AI’s Potential

Drug Solutions Podcast: Realizing AI’s Potential

Felicity Thomas
December 20th 2024
Podcast

This episode is a compilation of comments taken from a series of interviews where experts are discussing how AI might impact the global bio/pharma industry in the future.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

New Almac Pharma Services Commercial Manufacturing Facility Opens in Northern Ireland

Patrick Lavery
March 11th 2025
Article

The company’s 100,000-sq.-ft. space is expected to enhance its capabilities for commercial oral dose treatment manufacturing in a variety of therapeutic areas.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Stäubli Robotics Previews World’s First Cleanroom Mobile Robot for INTERPHEX Display

Patrick Lavery
March 11th 2025
Article

Sterimove will make its North American debut at the April 1–3, 2025 event.